Clinical Trial

Strategies to Minimize the Risk for Insulin Induced Hypertrophy and Its Related Consequences

Completed
View on ClinicalTrials.gov →
Summary
Hypertrophy caused by insulin has effects that extend beyond just aesthetic concerns. Innovative methods have shown potential in decreasing the chances of hypertrophy and its related issues, including the development of detailed diagrams of insulin injection locations and tailored rotation plans. This study aimed to assess the impact of a novel insulin injection sites map (digital or physical) on the incidence of insulin-induced hypertrophy, adherence to rotation protocols, glycemic control, and patient experience among diabetes patients treated with insulin between study and control group along six months of follow up
Trial Details
NCT Number NCT07375875
Lead Sponsor Mansoura University
Conditions Insulin Dependent Diabetes Mellitus
Enrollment 170 participants
Start Date 2025-05-15
Primary Completion 2025-12-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-29